Educational information, not medical advice — ask your doctor or midwife.
PSK (Polysaccharide-K), sold under the brand name Krestin in Japan, is a purified extract from the Turkey Tail mushroom (Trametes versicolor), one of the most common and recognizable fungi found worldwide. It has been used in Traditional Chinese Medicine under the name Yunzhi for centuries as an energy tonic and immune strengthener. Japan's Ministry of Health approved PSK as an adjunct cancer treatment in the 1970s, making it one of the very few mushroom-derived compounds to receive government-level clinical recognition.
PSK works primarily by activating key immune cells — including natural killer (NK) cells, T-cells, and macrophages — essentially helping your immune system identify and respond to threats more efficiently. It also binds to immune receptors (like Toll-like receptors) that act as early-warning signals in your body's defense network. On top of that, it appears to support a healthy gut microbiome, which plays a surprisingly large role in overall immune regulation.
Standardized PSK extract (as in Krestin tablets) is the most clinically studied form. In supplement markets outside Japan, Turkey Tail capsules or powders made from hot-water or dual extracts are widely available, though standardization varies significantly by brand. Look for products specifying beta-glucan content (ideally 20–40%) or labeled as PSK-standardized extract for best results.
Turkey Tail mushroom has been brewed as a medicinal tea in China and Japan for at least 2,000 years. Japanese researchers in the 1960s–70s isolated PSK from the mushroom and developed it into Krestin, which became one of the best-selling cancer adjunct drugs in Japan by the 1980s. Its use in oncology settings is more developed in Asia than in Western medicine, though global research interest has grown substantially since the 2010s.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.